SPECIFIC PHARMA A/S
CVR 33161395 · Public limited company (A/S) · Active · Low risk
SPECIFIC PHARMA A/S is a Public limited company (A/S), founded on , based in København SV. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 15 annual reports have been published. The latest annual report (31 Jan 2026) shows equity of DKK 98.6m and a net result of DKK 15.2m.
Bankruptcy risk for SPECIFIC PHARMA A/S
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 33161395
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (16 years)
- Address
- Borgmester Christiansens Gade 40
2450 København SV - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 5.0m
- Employees
- 24 (2018)
- Auditor
- Forvis Mazars Statsautoriseret Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 15 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 85.6% |
| Current ratio | 696% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | DKK 157.8m | DKK 219.3m | DKK 211.0m |
| Gross profit | DKK 38.2m | DKK 57.3m | DKK 48.5m |
| Net profit | DKK 15.2m | DKK 29.2m | DKK 25.6m |
| Equity | DKK 98.6m | DKK 111.2m | DKK 106.2m |
| Total assets | DKK 115.2m | DKK 134.5m | DKK 126.2m |
| Short-term debt | DKK 16.5m | DKK 23.1m | – |
| Avg. employees | 37 | 34 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Forvis Mazars Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Feb 2025 – 31 Jan 2026 | 146 | ||
| 1 Feb 2024 – 31 Jan 2025 | 151 | ||
| 1 Feb 2023 – 31 Jan 2024 | 149 | ||
| 1 Feb 2022 – 31 Jan 2023 | 157 | ||
| 1 Feb 2021 – 31 Jan 2022 | 156 | ||
| 1 Feb 2020 – 31 Jan 2021 | 145 | ||
| 1 Feb 2019 – 31 Jan 2020 | 147 | ||
| 1 Feb 2018 – 31 Jan 2019 | 140 | ||
| 1 Feb 2017 – 31 Jan 2018 | 148 | ||
| 1 Feb 2016 – 31 Jan 2017 | 149 | ||
| 1 Feb 2015 – 31 Jan 2016 | 138 | ||
| 1 Feb 2014 – 31 Jan 2015 | 110 | ||
| 1 Feb 2013 – 31 Jan 2014 | 115 | ||
| 1 Feb 2012 – 31 Jan 2013 | 118 | ||
| 15 Sep 2010 – 31 Jan 2012 | 140 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Søren Vesti Esbensen | Current | |
| Board | Ken Rasmussen | Current | |
| Board | Kristine Sakstrup Haag | Current | |
| Board | Henrik Kaastrup | Current | |
| Board | Kasper Casparij Yde | Current | |
| Board | Jan Bonde | ||
| Board | Ole Markussen | ||
| Board | Tina Majgård Moltke-Leth | ||
| Board | Søren Vesti Esbensen | ||
| Board | Kristine Sakstrup Haag | ||
| Board | Per Bornhøft Hansen | ||
| Board | Henrik Kaastrup | ||
| Board | Ole Markussen | ||
| Board | Pia Rask Stewart | ||
| Owner (100%) | NOMECO A/S | Current | |
| Auditor | Forvis Mazars Statsautoriseret Revisionspartnerselskab | Current | |
| Auditor | EY Danmark A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | NOMECO A/S | Current |
Address history (6 moves)
| Borgmester Christiansens Gade 40, 2450 København SV | |
| Tørringvej 7, 2. tv, 2610 Rødovre | |
| Borgmester Christiansens Gade 40, 2450 København SV | |
| Tørringvej 7, 2. tv, 2610 Rødovre | |
| Tørringvej 7, 2. th, 2610 Rødovre | |
| Sluseholmen 2, 2450 København SV | |
| Borgmester Christiansens Gade 40, 2450 København SV |
Employees per year
Other companies at the same address
- MECO HOLDING A/S Fusioneret
- NOMECO A/S Active
- NORDIC PHARMA INVEST A/S Fusioneret
- PHOENIX DANISH HOLDING A/S Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about SPECIFIC PHARMA A/S
Has SPECIFIC PHARMA A/S gone bankrupt?
No, SPECIFIC PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SPECIFIC PHARMA A/S?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the auditor of SPECIFIC PHARMA A/S?
SPECIFIC PHARMA A/S most recently used Forvis Mazars Statsautoriseret Revisionspartnerselskab.
When was SPECIFIC PHARMA A/S founded?
SPECIFIC PHARMA A/S was founded on 15 September 2010.
What is the equity of SPECIFIC PHARMA A/S?
Equity was DKK 98.6m according to the annual report for the period ending 31 January 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.